4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0001415889-22-006391
CHIEF EXECUTIVE OFFICER sold 5,104 shares at $365.00 ($1,862,960)
- CHIEF EXECUTIVE OFFICER acquired 5,104 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kummeth Charles R. CHIEF EXECUTIVE OFFICER | 2022-06-07 | Option exercise | +5,104 | $108.49 | $553,733 | 203,442 | D |
| Kummeth Charles R. CHIEF EXECUTIVE OFFICER | 2022-06-07 | Sale | −5,104 | $365.00 | $1,862,960 | 198,338 | D |
| Derivatives | |||||||
| Kummeth Charles R. CHIEF EXECUTIVE OFFICER | 2022-06-07 | Option exercise · Stock Option (right to buy) | −5,104 | 95,346 | D | ||
| Open-market sales · 5,104 sh · avg $365.00 · $1,862,960 | |||||||
Loading xslF345X03/form4-06092022_020617.xml…